Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro N Franciosi

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Respirology (Carlton, Vic.)|July 8, 2026
Not All Flares Are Equal: Stratifying Risk During Asthma/COPD Overlap ExacerbationsHelen O'Brien, Alessandro N Franciosi
JAMA|May 11, 2021
Pulmonary Embolism Prevalence Among Hospitalized Patients With COPDAlessandro N Franciosi, Cormac McCarthy
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 11, 2021
TeleHealth or TeleWealth? Equity challenges for the future of cystic fibrosis care (Commentary)Alessandro N Franciosi, Bradley S Quon
Respiratory Research|January 25, 2025
Risk of lung disease with the Pi*SS genotype of alpha-1 antitrypsin: the evidence in contextHelen O'Brien, Cormac McCarthy, Alessandro N Franciosi
Critical Care (London, England)|June 10, 2022
Reply to: "Hyperoxemia in postsurgical sepsis/septic shock patients is associated with reduced mortality"Alessandro N Franciosi, Cormac McCarthy, Ruth MacRedmond
The European Respiratory Journal|April 23, 2026
GOLD Stage 1 COPD pharmacotherapy: big question, few answersHelen O'Brien, Cormac McCarthy, Alessandro N Franciosi
European Heart Journal|March 4, 2025
Unilateral pulmonary oedemaWilliam Griffin, Charles McCreery, Alessandro N Franciosi
The European Respiratory Journal|June 15, 2023
Questioning the purpose of annual follow-up spirometry for all patients with COPDJehangir Khan, Cormac McCarthy, Alessandro N Franciosi
Current Opinion in Pulmonary Medicine|February 10, 2026
GLP-1 receptor agonists in asthma: targeting metabolic-inflammatory crossroadsHelen O'Brien, Alessandro N Franciosi, Marcus W Butler
Expert Review of Respiratory Medicine|January 20, 2015
The efficacy and safety of inhaled human α-1 antitrypsin in people with α-1 antitrypsin deficiency-related emphysemaAlessandro N Franciosi, Cormac McCarthy, Noel Gerry McElvaney
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Respirology (Carlton, Vic.)|July 8, 2026
Not All Flares Are Equal: Stratifying Risk During Asthma/COPD Overlap ExacerbationsHelen O'Brien, Alessandro N Franciosi
JAMA|May 11, 2021
Pulmonary Embolism Prevalence Among Hospitalized Patients With COPDAlessandro N Franciosi, Cormac McCarthy
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 11, 2021
TeleHealth or TeleWealth? Equity challenges for the future of cystic fibrosis care (Commentary)Alessandro N Franciosi, Bradley S Quon
Respiratory Research|January 25, 2025
Risk of lung disease with the Pi*SS genotype of alpha-1 antitrypsin: the evidence in contextHelen O'Brien, Cormac McCarthy, Alessandro N Franciosi
Critical Care (London, England)|June 10, 2022
Reply to: "Hyperoxemia in postsurgical sepsis/septic shock patients is associated with reduced mortality"Alessandro N Franciosi, Cormac McCarthy, Ruth MacRedmond
The European Respiratory Journal|April 23, 2026
GOLD Stage 1 COPD pharmacotherapy: big question, few answersHelen O'Brien, Cormac McCarthy, Alessandro N Franciosi
European Heart Journal|March 4, 2025
Unilateral pulmonary oedemaWilliam Griffin, Charles McCreery, Alessandro N Franciosi
The European Respiratory Journal|June 15, 2023
Questioning the purpose of annual follow-up spirometry for all patients with COPDJehangir Khan, Cormac McCarthy, Alessandro N Franciosi
Current Opinion in Pulmonary Medicine|February 10, 2026
GLP-1 receptor agonists in asthma: targeting metabolic-inflammatory crossroadsHelen O'Brien, Alessandro N Franciosi, Marcus W Butler
Expert Review of Respiratory Medicine|January 20, 2015
The efficacy and safety of inhaled human α-1 antitrypsin in people with α-1 antitrypsin deficiency-related emphysemaAlessandro N Franciosi, Cormac McCarthy, Noel Gerry McElvaney
Pageof 5